Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion type Assertion NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_head.
- NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion description "[The MxA promoter with haplotype -88T/-123A confers greater expression of MxA in vitro, as well as a better treatment outcome for chronic hepatitis C patients treated with interferon in vivo, as compared to the MxA promoter with haplotype -88G/-123C.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_provenance.
- NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion evidence source_evidence_literature NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_provenance.
- NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion SIO_000772 11805446 NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_provenance.
- NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion wasDerivedFrom lhgdn-20090331 NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_provenance.
- NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_assertion wasGeneratedBy ECO_0000203 NP138436.RAyQlIUh4uythjmfABuPSwTF9WIDeXW5jt5d3t4mZAyIQ130_provenance.